Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02020707
Brief Title: Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma, Gynecological or Other Cancers

First Submitted : December 19, 2013
First Submitted that Met QC Criteria : December 19, 2013
First Posted : December 25, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : February 24, 2021
Last Update Posted : February 25, 2021